Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The methylphenidate test for differentiating desipramine-responsive from nortriptyline-responsive depression.

H C Sabelli, J Fawcett, J I Javaid

    The American Journal of Psychiatry
    |February 1, 1983
    PubMed
    Summary

    Plasma levels of tricyclic antidepressants (TCAs) vary in effectiveness for major depressive disorder. A methylphenidate test may predict patient response to specific TCAs, highlighting depression heterogeneity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Retrospective spatial analysis of cases of COVID-19 in a single military accommodation block corridor, RMAS, January-March 21.

    BMJ military health·2022
    Same author

    Efficacy and Toxicity of Stereotactic Body Radiotherapy for Early to Advanced Stage Hepatocellular Carcinoma - Initial Experience From an Australian Liver Cancer Service.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2020
    Same author

    How can schistosome circulating antigen assays be best applied for diagnosing male genital schistosomiasis (MGS): an appraisal using exemplar MGS cases from a longitudinal cohort study among fishermen on the south shoreline of Lake Malawi.

    Parasitology·2019
    Same author

    Recent advances in the therapeutic uses of chondroitinase ABC.

    Experimental neurology·2019
    Same author

    Mortality from Listeria monocytogenes meningoencephalitis following escalation to alemtuzumab therapy for relapsing-remitting Multiple Sclerosis.

    Multiple sclerosis and related disorders·2018
    Same author

    The role of macrophages in the development of biliary injury in a lipopolysaccharide-aggravated hepatic ischaemia-reperfusion model.

    Biochimica et biophysica acta. Molecular basis of disease·2017

    Area of Science:

    • Pharmacology
    • Psychiatry
    • Neuroscience

    Background:

    • Major depressive disorder (MDD) treatment involves tricyclic antidepressants (TCAs).
    • Individual patient responses to TCAs can vary significantly, even within therapeutic plasma concentration ranges.
    • Understanding differential drug efficacy is crucial for optimizing MDD treatment strategies.

    Purpose of the Study:

    • To investigate differential patient responses to specific TCAs (imipramine, desipramine, amitriptyline, nortriptyline).
    • To evaluate the predictive utility of a methylphenidate challenge test for TCA treatment outcomes.
    • To explore the heterogeneity of depressive disorders based on drug response patterns.

    Main Methods:

    • Plasma concentrations of TCAs were monitored in 43 patients with MDD.

    Related Experiment Videos

  • Patients received treatments including imipramine, desipramine, amitriptyline, and nortriptyline.
  • A methylphenidate challenge test was administered to assess mood elevation as a predictor of treatment response.

    • Main Results:

    • Some patients responded to imipramine/desipramine but not amitriptyline/nortriptyline, and vice versa, despite therapeutic plasma levels.
    • Positive mood elevation with methylphenidate predicted significant improvement with imipramine/desipramine, but not amitriptyline/nortriptyline.
    • Failure of methylphenidate to elevate mood predicted response to amitriptyline/nortriptyline, but not desipramine.

    Conclusions:

    • Significant inter-individual variability exists in TCA efficacy, suggesting differential drug responses.
    • The methylphenidate test shows potential clinical utility in predicting patient response to specific TCAs.
    • Observed differential responses underscore the heterogeneity of major depressive disorders.